Bessemer Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Bessemer Group's ATRC Position: Q2 2026 in Review
Bessemer Group sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 9,570 shares — an estimated $273K sold.
Bessemer Group first reported a position in ATRC in Q4 2018 and held it in 20 quarters. The position peaked at $2.5M in Q2 2019. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Bessemer Group reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
- Bessemer Group sold 9,570 AtriCure shares in Q2 2026, an estimated $273K.
- Bessemer Group first reported a position in AtriCure in Q4 2018 and held it in 20 quarters.
- Bessemer Group's AtriCure position peaked at $2.5M in Q2 2019.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.